A clinical trial of domatinostat plus Rapamycin in cancers, such as recurrent metastatic osteosarcoma and refractory sarcomas
Latest Information Update: 27 Jun 2024
At a glance
- Drugs Domatinostat (Primary) ; Sirolimus
- Indications Cancer; Osteosarcoma; Sarcoma
- Focus Adverse reactions
Most Recent Events
- 27 Jun 2024 New trial record
- 20 Jun 2024 According to 4SC AG media release, company expects to begin the first clinical studies in late 2024.